Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
---|---|---|---|---|---|---|---|---|
CAP18 | Communication and Care Coordination | Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic Colorectal Carcinoma | Process | Registry | Details | |||
CAP17 | Communication and Care Coordination | FMS-like Tyrosine 3-Internal Tandem Duplication (FLT3-ITD) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Acute Myeloid Leukemia | Process | Registry | Details | |||
CAP16 | Communication and Care Coordination | Epidermal Growth Factor Receptor (EGFR) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Process | Registry | Details | |||
CAP15 | Communication and Care Coordination | BRAF Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Metastatic Colorectal Adenocarcinoma | Process | Registry | Details | |||
CAP13 | Communication and Care Coordination | Anaplastic Lymphoma Kinase (ALK) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer | Process | Registry | Details | |||
CAP12 | Communication and Care Coordination | Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Gastroesophageal Adenocarcinoma | Process | Registry | Details | |||
CAP11 | Communication and Care Coordination | Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Breast Carcinoma | Process | Registry | Details | |||
CAP10 | Effective Clinical Care | Blood Laboratory Samples for Potassium Determination with Hemolysis Drawn in ED | Intermediate Outcome | Registry | Details | |||
ASPS9 | Efficiency and Cost Reduction | Length of Stay Following Autologous Breast Reconstruction | Outcome | Registry | Details | |||
ASPS8 | Communication and Care Coordination | Coordination of Care for Patients Undergoing Breast Reconstruction | Process | Registry | Details | |||
ASPS7 | Patient Safety | Rate of Blood Transfusion for Patients Undergoing Autologous Breast Reconstruction | Outcome | Registry | Details | |||
ASPS5 | Patient Safety | Breast Reconstruction: Return to OR | Outcome | Registry | Details | |||
ASPS26 | Person and Caregiver Centered Experience and Outcomes | Patient Satisfaction with Information Prior to Facial Reconstruction After Skin Cancer Resection Procedures | Outcome | Registry | Details | |||
ASPS25 | Effective Clinical Care | Avoidance of Post-operative Systemic Antibiotics for Office-based Reconstruction After Skin Cancer Resection Procedures | Process | Registry | Details | |||
ASPS24 | Efficiency and Cost Reduction | Visits to the ER or Urgent Care Following Reconstruction After Skin Cancer Resection | Outcome | Registry | Details | |||
ASPS23 | Patient Safety | Avoidance of Opioid Prescriptions for Reconstruction After Skin Cancer Resection | Process | Registry | Details | |||
ASPS22 | Communication and Care Coordination | Coordination of Care for Anticoagulated Patients Undergoing Reconstruction After Skin Cancer Resection | Process | Registry | Details | |||
ASPS21 | Patient Safety | Continuation of Anticoagulation Therapy in the Office-based Setting for Reconstruction After Skin Cancer Resection Procedures | Process | Registry | Details | |||
ASPS18 | Patient Safety | Shared-decision making for post-operative management of discomfort following Rhinoplasty | Process | Registry | Details | |||
ASPS17 | Person and Caregiver Centered Experience and Outcomes | Patient Satisfaction with Rhinoplasty Procedure | Outcome | Registry | Details |